BDR Pharmaceuticals, a leading pharmaceutical company, has launched a new generic antibiotic under brand name Xavitaz which is a combination of ceftazidime and avibactum. The drug will be effective in treating gram negative infections (hospital-acquired & ventilator-associated pneumonia, intra-abdominal infections and complicated UTIs). Previously, only the imported version of the drug was available, which may have resulted in limited availability across various locations. Given the high demand for the drug, BDR is now launching a new antibiotic in his segment that will be easier to find for the treating physician. Xavitaz is a combination of 2g ceftazidime and 500mg avibactam, this combination is useful in treating resistant gram-negative infections, including those caused by pseudomonas aeruginosa and many ceftazidime resistant strains. Hospital-acquired and ventilator-associated pneumonia, two main types of community-acquired pneumonia (which is the most common type of pneumonia in India, affecting 4 million people per year and hospitalising 20 per cent of them). Intra-abdominal infections, along with two other syndromes, accounted for 7.7 million deaths worldwide, in 2019. Raheel Shah, director of business development, BDR Group, stated, "Ensuring that all patients have access to quality-produced, world-class treatment was the main reason for launching the drug in India. BDR Pharma has a vision of strengthening the R&D department and works in accordance with the needs of the people. We are extremely pleased with the launch of ceftazidime avibactum because it will add to the repertoire of physicians treating infections.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!